Oxford BioDynamics Plc (LON:OBD – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 0.15 and last traded at GBX 0.16, with a volume of 16345429 shares. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Trading Down 9.9%
The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The firm has a market capitalization of £6.65 million, a price-to-earnings ratio of -0.19 and a beta of 0.42. The company has a 50-day moving average price of GBX 0.19 and a 200-day moving average price of GBX 0.23.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here
- Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout
- 3 Stocks Building the Future of Agentic AI Payments
- This Single Factor Is Holding Back Carvana’s Disruptive Edge
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
